Lv3
320 积分 2022-03-12 加入
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial
1天前
已关闭
Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
3个月前
已完结
Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis
5个月前
已完结
Current Status in Rechallenge of Immunotherapy
5个月前
已关闭
Neoadjuvant and Adjuvant Treatment for Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): Consensus Recommendations from the International Association for the Study of Lung Cancer (IASLC)
6个月前
已完结
How Do I Manage Refractory Invasive Pulmonary Aspergillosis
1年前
已关闭
How Do I Manage Refractory Invasive Pulmonary Aspergillosis
1年前
已关闭
Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis?
1年前
已完结
How Do I Manage Refractory Invasive Pulmonary Aspergillosis
1年前
已关闭
How Do I Manage Refractory Invasive Pulmonary Aspergillosis
1年前
已关闭
皖公网安备34019202002308
